For instance, between 1996 and 2002, in Demark alone, the period when growth promotant use of antibiotics was withdrawn, the total amount used for therapeutic purposes nearly doubled; from 48,000 kg in 1996 to 94,300 kg in 2002 (WHO, 2003). Specific classes that are used for enteropathies and scouring, such as macrolides and lincosamides nearly tripled (7,600 kg in 1996 to 21,200 in 2002).